In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review
<p>Abstract</p> <p>Background</p> <p>Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of <it>in vitro <...
Main Authors: | Blackmore Stuart, Gillard Samantha, Brown Adam P, Trew Geoffrey H, Clewlow Christine, O'Donohoe Paul, Wasiak Radoslaw |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/8/1/137 |
Similar Items
-
Comparison of Human Menopausal Gonadotrophin and Recombinant Follicle-Stimulating Hormone in In-Vitro Fertilisation and Pregnancy Outcome
by: Phakphum Phophong, et al.
Published: (2020-08-01) -
The effect of purified gonadotrophins on the ovarian structure
by: El-Tomi, N. F.
Published: (1979) -
Comparison of Effectiveness between Recombinant Follicle Stimulating Hormone and Human Menopausal Gonadotrophin Administration in those with Diminished Ovarian Reserve
by: Phakphum Ponphong, et al.
Published: (2002-01-01) -
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
by: Ezcurra Diego, et al.
Published: (2010-09-01) -
In vitro fertilisation in women with polycystic ovary syndrome : the impact of gonadotrophin stimulation on metabolic variables
by: Simonis, Chantal Dominique
Published: (2010)